Skip to main content
Caplight Logo









Neurode

Neurode

Private
SydneyHealthcare & Life Scienceshttps://neurodelabs.com/

Last Round

Grant

Sep 21, 2025

Total Funding Raised

$5.55M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Neurode is a healthtech company that develops a wearable headset and accompanying mobile application designed to monitor and treat ADHD symptoms through non-invasive electrical brain stimulation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Health IoT, D2C Brands

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

neurotechnologywearable devicebrain-computer interfaceBCIneuro-monitoringdigital healthfunctional near-infrared spectroscopyfNIRSADHD managementclosed-loop stimulationbiohackingmental health techcognitive healthDTC hardwarebrain-sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurode Comparables

Compare Neurode with similar companies based on industry and business-model similarity.

Neurode comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mendi Innovations
82%
Myndlift
78%
Flow Neuroscience
77%

Neurode Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 21, 2025
Pre SeedSep 11, 2024

Neurode Investors

Notable investors and investment history

Neurode investors
InvestorRounds
Khosla VenturesPre Seed
SOSVAccelerator, Pre Seed
HAXAccelerator, Pre Seed
Stoic Venture CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 45% MoM.

  • May 19, 2026

    Monthly visitors increased 87% MoM, reaching 14.8K.

Neurode Filings

Explore SEC and related filing metadata, where available.

Neurode filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neurode's valuation, stock price, and market status.

Is Neurode a public or private company?

Neurode is a private company.

What is the current stock price of Neurode?

Neurode is a private company with no public stock price. No recent secondary market data is available.

How much is Neurode worth (valuation)?

Valuation information for Neurode is not publicly available.

Can I buy Neurode stock?

Neurode shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neurode's last funding round?

Neurode's most recent funding round was Pre Seed on September 10, 2024.

Who are the main investors in Neurode?

Key investors in Neurode include Khosla Ventures.

Will Neurode IPO soon?

No public IPO plans have been announced for Neurode.

How can I track Neurode secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurode's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range10
Year Founded2021
Last FundingSep 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?